ATE451100T1 - Pharmazeutische wundheilungszusammensetzungen in form einer crome auf basis von aminosäuren und natriumhyaluronat - Google Patents

Pharmazeutische wundheilungszusammensetzungen in form einer crome auf basis von aminosäuren und natriumhyaluronat

Info

Publication number: ATE451100T1
Authority: AT; Austria
Prior art keywords: amino acids; sodium hyaluronate; crome; wound healing; healing compositions
Prior art date: 2005-10-26

Application number

AT06806303T

Other languages

English (en)

Inventor

Franco Conti

Original Assignee

Solartium Entpr Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-10-26

Filing date

2006-10-16

Publication date

2009-12-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37696025&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE451100(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-10-16 Application filed by Solartium Entpr Ltd filed Critical Solartium Entpr Ltd

2009-12-15 Application granted granted Critical

2009-12-15 Publication of ATE451100T1 publication Critical patent/ATE451100T1/de

Links

229920002385 Sodium hyaluronate Polymers 0.000 title abstract 2
150000001413 amino acids Chemical class 0.000 title abstract 2
239000000203 mixture Substances 0.000 title abstract 2
229940010747 sodium hyaluronate Drugs 0.000 title abstract 2
YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 title abstract 2
230000029663 wound healing Effects 0.000 title abstract 2
230000032683 aging Effects 0.000 abstract 1
239000002537 cosmetic Substances 0.000 abstract 1
239000006071 cream Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Dermatology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Toxicology (AREA)
Biochemistry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)

AT06806303T 2005-10-26 2006-10-16 Pharmazeutische wundheilungszusammensetzungen in form einer crome auf basis von aminosäuren und natriumhyaluronat ATE451100T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT002035A ITMI20052035A1 (it)	2005-10-26	2005-10-26	Composizioni farmaceutiche cicatrizzanti sotto forma di crema a base di amminoacidi e sodio ialuronato
PCT/EP2006/009966 WO2007048522A1 (en)	2005-10-26	2006-10-16	Wound-healing pharmaceutical compositions in the form of a cream based on amino acids and sodium hyaluronate

Publications (1)

Publication Number	Publication Date
ATE451100T1 true ATE451100T1 (de)	2009-12-15

Family

ID=37696025

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT06806303T ATE451100T1 (de)	2005-10-26	2006-10-16	Pharmazeutische wundheilungszusammensetzungen in form einer crome auf basis von aminosäuren und natriumhyaluronat

Country Status (11)

Country	Link
US (2)	US20080287392A1 (de)
EP (1)	EP1951219B1 (de)
JP (1)	JP5203955B2 (de)
KR (1)	KR101583746B1 (de)
AT (1)	ATE451100T1 (de)
CA (1)	CA2627214C (de)
DE (1)	DE602006011048D1 (de)
ES (1)	ES2335436T3 (de)
IT (1)	ITMI20052035A1 (de)
PL (1)	PL1951219T3 (de)
WO (1)	WO2007048522A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ITMI20052035A1 (it) *	2005-10-26	2007-04-27	Professional Dietetics Srl	Composizioni farmaceutiche cicatrizzanti sotto forma di crema a base di amminoacidi e sodio ialuronato
ITMI20052037A1 (it) *	2005-10-26	2007-04-27	Professional Dietetics Srl	Composizioni farmaceutiche cicatrizzanti sotto forma di polvere sterile a base di amminoacidi e sodio ialuronato
ITMI20052036A1 (it) *	2005-10-26	2007-04-27	Professional Dietetics Srl	Composizioni farmaceutiche oftalmiche a base di amminoacidi e sodio ialuronato
IT1396935B1 (it) *	2009-11-26	2012-12-20	Solartium Entpr Ltd	Uso di una combinazione per il trattamento delle mucositi indotte da radiazioni o da chemioterapici
ITMI20110954A1 (it) *	2011-05-26	2012-11-27	Professional Dietetics Srl	Combinazioni per il trattamento delle mucositi vaginali o rettali
US8642665B2 (en) *	2011-12-16	2014-02-04	Conopco, Inc.	Environmentally friendly, low whitening compositions
JP2015533190A (ja)	2012-10-09	2015-11-19	シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニＳｉｇｍａ−ＴａｕＩｎｄｕｓｔｒｉｅＦａｒｍａｃｅｕｔｉｃｈｅＲｉｕｎｉｔｅＳｏｃｉｅｔａＰｅｒＡｚｉｏｎｉ	修飾されたヒアルロン酸誘導体およびその使用
WO2014093645A2 (en) *	2012-12-13	2014-06-19	Precision Dermatology, Inc.	Topical formulations for increasing the dermal concentration of hyaluronic acid
GR1008308B (el)	2013-05-31	2014-10-02	UNI-PHARMA ΚΛΕΩΝ ΤΣΕΤΗΣ ΦΑΡΜΑΚΕΥΤΙΚΑ ΕΡΓΑΣΤΗΡΙΑ ΑΒΕΕ με δ.τ. "UNI-PHARMA ABEE",	Τοπικες φαρμακευτικες και ιατροτεχνολογικες συνθεσεις που περιεχουν συνδυασμους σουκραλφατης, υαλουρονικου οξεος, αργινινης και ενος φυσικου ενυδατικου παραγοντα
ITMI20131660A1 (it)	2013-10-08	2015-04-09	Professional Dietetics Srl	Uso di una combinazione per la prevenzione delle mucositi indotte da radiazioni o da chemioterapici
JP6726182B2 (ja)	2014-12-04	2020-07-22	プロフェスィオナルディエテティクスソシエタペルアチオニＰｒｏｆｅｓｓｉｏｎａｌＤｉｅｔｅｔｉｃｓＳ．Ｐ．Ａ．	真皮結合組織中のフィブロエラスチンの回復用途のアミノ酸系組成物
US12337056B2 (en)	2018-05-29	2025-06-24	Mary Kay Inc.	Topical compositions and methods
KR20200047220A (ko)	2018-10-27	2020-05-07	장정훈	창상, 당뇨병성 족부/손 궤양 또는 버거씨병 치료용 약학 조성물
KR102072948B1 (ko)	2019-08-06	2020-02-04	주식회사 씨엔엘바이오텍	염증치료용 약학적 발효 조성물
KR102072947B1 (ko)	2019-08-06	2020-02-04	주식회사 씨엔엘바이오텍	상처치유 또는 피부재생 촉진용 약학 조성물
WO2021191811A1 (en)	2020-03-24	2021-09-30	Acupharm Investments (Pty) Limited	A novel wound gel composition
CN113260367B (zh) *	2020-09-02	2024-01-12	弹性实验室有限公司	用于促进结缔组织中弹性蛋白和胶原蛋白生物合成的组合物
KR102226810B1 (ko)	2020-09-02	2021-03-15	주식회사 엘라스틱랩	연결 조직 중 엘라스틴 및 콜라겐 생합성 증진용 조성물
IT202100023921A1 (it) *	2021-09-21	2023-03-21	Casadei Elena Francesca	Composizione per il trattamento analgesico e riepitelizzante del tessuto vulvo-vaginale e perineale.
CN120152696A (zh) *	2022-11-02	2025-06-13	株式会社Lg生活健康	用于改善皮肤的复合物
EP4574145A1 (de)	2023-12-21	2025-06-25	Paul Hartmann Aktiengesellschaft	Zusammensetzung mit aminosäuren, metabolisierbarer komponente und lipidkomponente
WO2025196725A1 (en) *	2024-03-22	2025-09-25	The Wave Innovation Group S.R.L.	Patent application for the industrial invention entitled: a composition based on hyaluronic acid and amino acids for use in the treatment of periodontal wounds

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4707354A (en) *	1985-06-17	1987-11-17	Alpen Tau, Inc.	Mature skin treatment and protectant compositions and methods of using same
IT1240316B (it) *	1990-02-21	1993-12-07	Ricerca Di Schiena Del Dr. Michele G. Di Schiema & C.	Composizioni a base di acido ialuronico ad alto peso molecolare somministrabili per via topica per il trattamento di infiammazioni del cavo orale ,per la cosmetica e l'igiene del cavo orale
WO1996003158A1 (en) *	1994-07-22	1996-02-08	Alcon Laboratories, Inc.	Use of low molecular weight amino acids in ophthalmic compositions
US6541460B2 (en) *	1996-08-07	2003-04-01	George D. Petito	Method for use of hyaluronic acid in wound management
US6645948B2 (en) *	1998-03-24	2003-11-11	George D. Petito	Nutritional composition for the treatment of connective tissue
IT1304191B1 (it) *	1998-12-18	2001-03-08	Solartium Establishment	Composizione farmaceutica a base di prolina, glicina e lisina utilenella terapia odontoiatrica sia sotto forma iniettabile che in
IT1318556B1 (it) *	2000-06-07	2003-08-27	Solartium Establishment	Composizione farmaceutica a base di prolina, glicina e lisina utilenella terapia per la cicatrizzazione delle ferite e delle lesioni
FR2820635B1 (fr) *	2001-02-09	2005-01-21	Genevrier Lab	Procede de preparation d'une creme a base d'acide hyaluronique
ITTO20010804A1 (it) *	2001-08-08	2003-02-08	Professional Dietetics Srl	Composizioni a base di aminoacidi, idonee alla terapia per la cicatrizzazione e/o riparazione di ferite e lesioni, in particolare per l'appl
US20040265268A1 (en) *	2001-08-18	2004-12-30	Deepak Jain	Compositions and methods for skin rejuvenation and repair
US6780841B2 (en) *	2001-11-13	2004-08-24	Biocell Technology, Llc	Hyaluronic acid and chondroitin sulfate based hydrolyzed collagen type II and method of making same
US20040180025A1 (en) *	2003-03-12	2004-09-16	New Life Resources, Llc	Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations
FR2864445B1 (fr) *	2003-12-30	2006-04-28	Jean Noel Thorel	Utilisation topique d'une base nutritive complexe
ITMI20052036A1 (it) *	2005-10-26	2007-04-27	Professional Dietetics Srl	Composizioni farmaceutiche oftalmiche a base di amminoacidi e sodio ialuronato
ITMI20052035A1 (it)	2005-10-26	2007-04-27	Professional Dietetics Srl	Composizioni farmaceutiche cicatrizzanti sotto forma di crema a base di amminoacidi e sodio ialuronato
ITMI20052037A1 (it) *	2005-10-26	2007-04-27	Professional Dietetics Srl	Composizioni farmaceutiche cicatrizzanti sotto forma di polvere sterile a base di amminoacidi e sodio ialuronato

2005
- 2005-10-26 IT IT002035A patent/ITMI20052035A1/it unknown
2006
- 2006-10-16 JP JP2008536973A patent/JP5203955B2/ja active Active
- 2006-10-16 PL PL06806303T patent/PL1951219T3/pl unknown
- 2006-10-16 WO PCT/EP2006/009966 patent/WO2007048522A1/en not_active Ceased
- 2006-10-16 EP EP06806303A patent/EP1951219B1/de active Active
- 2006-10-16 AT AT06806303T patent/ATE451100T1/de not_active IP Right Cessation
- 2006-10-16 DE DE602006011048T patent/DE602006011048D1/de active Active
- 2006-10-16 KR KR1020087009860A patent/KR101583746B1/ko active Active
- 2006-10-16 CA CA2627214A patent/CA2627214C/en active Active
- 2006-10-16 ES ES06806303T patent/ES2335436T3/es active Active
- 2006-10-16 US US12/091,462 patent/US20080287392A1/en not_active Abandoned
2010
- 2010-11-26 US US12/954,840 patent/US8404661B2/en active Active

Also Published As

Publication number	Publication date
PL1951219T3 (pl)	2010-05-31
CA2627214A1 (en)	2007-05-03
EP1951219A1 (de)	2008-08-06
WO2007048522A1 (en)	2007-05-03
JP2009513585A (ja)	2009-04-02
ITMI20052035A1 (it)	2007-04-27
ES2335436T3 (es)	2010-03-26
KR101583746B1 (ko)	2016-01-19
EP1951219B1 (de)	2009-12-09
US20110071105A1 (en)	2011-03-24
US20080287392A1 (en)	2008-11-20
DE602006011048D1 (de)	2010-01-21
KR20080068027A (ko)	2008-07-22
US8404661B2 (en)	2013-03-26
JP5203955B2 (ja)	2013-06-05
CA2627214C (en)	2015-03-10

Legal Events

Date	Code	Title	Description
2010-06-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE451100T1 (de)	2009-12-15	Pharmazeutische wundheilungszusammensetzungen in form einer crome auf basis von aminosäuren und natriumhyaluronat
ATE451916T1 (de)	2010-01-15	Ophthalmische pharmazeutische zusammensetzungen auf basis von aminosäuren und natriumhyaluronat
BRPI0510428A (pt)	2007-10-30	composições tópicas de metadona e processos para utilização das mesmas
ATE350010T1 (de)	2007-01-15	Zusammensetzung zur topischen anwendung
WO2004012650A3 (fr)	2004-04-15	Compositions cosmetiques ou dermopharmaceutiques comprenant du kombucha.
WO2006136607A3 (de)	2007-05-31	Verwendung von hydrophobin-polypeptiden sowie konjugaten aus hydrophobin-polypeptiden mit wirk- oder effektstoffen und ihre herstellung sowie deren einsatz in der kosmetik
WO2008118017A3 (en)	2008-12-31	Prame derived peptides and immunogenic compositions comprising these
ES2330291B1 (es)	2010-10-18	Peptidos utiles en el tratamiento de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas.
EA200802364A1 (ru)	2009-06-30	Композиция для ухода за кожей и ее применение
CY1115961T1 (el)	2017-01-25	Ανυδρη μορφη κρυσταλλικης μηλεϊνικης ορβεπιταντης (orvepitant maleate)
ATE549353T1 (de)	2012-03-15	Aktive varianten des il-18 bindenden proteins und dessen medizinische verwendungen
CY1109733T1 (el)	2014-09-10	Χρησιμοποιηση πολυαιθυλενο γλυκολης για τη θεραπεια παθησεων ασθενειων και τραυματων, που εχουν σχεση με φλεγμονη
WO2008148966A3 (fr)	2009-06-18	Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations
CY1108607T1 (el)	2014-04-09	Συνθεσεις περιλαμβανουσες ζελατινη-γλυκινη και καροτενοειδη
BRPI0707420A8 (pt)	2019-01-15	composições contendo peptídeos com aminoácidos e métodos não naturais do uso
DE60307665D1 (de)	2006-09-28	Haarbehandlungszusammensetzungen mit xanthin und alpha-hydroxysäure
CY1118967T1 (el)	2018-01-10	Φαρμακευτικες συνθεσεις υψηλης δοσης βιοτινης
DE60226962D1 (de)	2008-07-17	Pharmazeutische zusammensetzung auf der basis von azaliden für lokale anwendung in der ophtalmologie
ATE498413T1 (de)	2011-03-15	Pharmazeutische wundheilungs-zusammensetzungen in form eines sterilen pulvers auf basis von aminosäuren und natriumhyaluronat
UY27827A1 (es)	2003-12-31	Composiciones y su uso terapeutico
EA200602002A1 (ru)	2007-02-27	Применение спинозинов для заживления ран
WO2008129180A3 (fr)	2009-05-22	Nouveaux facteurs viii pour le traitement des hemophiles de type a
CL2008000707A1 (es)	2008-09-22	Conjugado de polipeptidos antifusogenicos y polipeptidos derivados de la cabeza globular del factor del complemento c1q; composicion farmaceutica que lo comprende; su uso para tratar infecciones viricas; y metodo de produccion.
FR2867683B1 (fr)	2012-12-21	Compositions cosmetiques ou dermatologiques et leurs applications
DE602006010852D1 (de)	2010-01-14	Proliferationshemmendes arzneimittel